DK Life Science Co., Ltd.
Research DK Life Science Co., Ltd. (303810.KQ) on Bullrun: market cap KRW 80.44B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker303810.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyKRW
- Market capKRW 80.44B
- Financial periodQ2 2026
- RevenueKRW 24.26B
- Net income-KRW 887.87M
- Free cash flowKRW 1.85B
- Gross margin18.6%
Valuation Snapshot
latest market cap is KRW 80.44B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 80.44B | n/a | n/a | n/a |
Dividend history
About DK Life Science Co., Ltd.
DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is DK Life Science Co., Ltd.'s market cap?
DK Life Science Co., Ltd.'s market capitalization is KRW 80.44B.
What does DK Life Science Co., Ltd. do?
DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.